Business Information
The group’s principle activity is to provide pharmaceuticals, vaccines and diagnostics products. The group operates through four segments namely, pharmaceuticals, vaccines and diagnostics, sandoz, and consumer health. The group operates from the Canada, Europe, Asia Pacific, Africa and Australia.
|
|
Name |
Title
|
Email
|
| Daniel Vasella | Chmn., CEO | N/A | | Hans-Joerg Rudloff | Vice Chmn. | N/A | | Ulrich Lehner | Vice Chmn. | N/A | | Andreas Rummelt | CEO - Sandoz | N/A | | Joerg Reinhardt | CEO - Vaccines, Diagnostics | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 36,749,000 | 5,264,000 | | 2005 | 32,526,000 | 5,190,000 | | 2004 | 28,247,000 | 4,989,000
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
